We are excited to announce to you the biological molecule of interest for SensUs 2019 competition!
This years molecule for detection will be Etanercept.
Etanercept is a fusion protein that is found in the body after breakdown of the pharmaceutical drug necessary to treat Rheumatoid Arthritis (RA) or Rheumatic disease. It works by inhibiting TNF-alpha (Tumor Necrosis Factor-alpha), which is a key regulator in inflammatory immune response.
Rheumatoid arthritis is currently stated to affect over 120 million people (at least a quarter of a million people) on World Arthritis Day. It is a painful autoimmune disease causing inflammation and joint pain.
Our goal for this upcoming year is to build a device that can help patients and providers better manage Rheumatoid Arthritis (along with other inflammatory autoimmune diseases). And help improve their quality of life.
Here is a short video about it so you can learn more. We hope you will join us in the fight to help patients that are living with inflammatory autoimmune disease.